8C01.2/G61 Subacute inflammatory demyelinating polyneuropathy



Subacute inflammatory demyelinating polyneuropathy (SIDP) is an autoimmune disorder characterized by inflammation and destruction of the myelin sheath that surrounds and insulates peripheral nerve fibers. It is caused by an abnormal immune response, which leads to the destruction of the myelin sheath, resulting in neurological symptoms.


SIDP is typically diagnosed based on a combination of physical examination findings, laboratory tests, and imaging studies. Commonly used laboratory tests include complete blood count, erythrocyte sedimentation rate, and nerve conduction studies. Imaging studies such as MRI and CT scans may be used to assess the extent of the damage to the myelin sheath and determine the location of any lesions.

Differential diagnosis

Differential diagnosis of SIDP includes other autoimmune disorders, such as Guillain-Barré syndrome, as well as metabolic and toxic neuropathies, infections, and neurodegenerative disorders.


Treatment of SIDP typically involves immunosuppressive medications such as corticosteroids and intravenous immunoglobulin (IVIG). Other treatments may include physical therapy, occupational therapy, and medications to manage symptoms and reduce pain.


The prognosis for SIDP is typically good, with most patients achieving full recovery. However, some patients may experience residual weakness or sensory disturbances.

How medically accurate was this information?

Click on a star to rate it

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

DISCLAIMER: Please note that all explAInations are generated by AI and are not fact checked by a medical professional. ICD ExplAIned do not assume liability for any injuries or harm based on the use of this medical information.